Sionna Therapeutics (SION) Current Assets (2024 - 2026)
Quarterly results put Current Assets at $221.0 million for Q1 2026, down 19.26% from a year ago — trailing twelve months through Mar 2026 was $221.0 million (down 19.26% YoY), and the annual figure for FY2025 was $241.4 million, up 59.89%.
Sionna Therapeutics has reported Current Assets over the past 3 years, most recently at $221.0 million for Q1 2026.
- Current Assets reached $221.0 million in Q1 2026 per SION's latest filing, down from $241.4 million in the prior quarter.
- Across five years, Current Assets topped out at $273.7 million in Q1 2025 and bottomed at $151.0 million in Q4 2024.
- Median Current Assets over the past 3 years was $246.9 million (2025), compared with a mean of $234.4 million.
- The largest annual shift saw Current Assets skyrocketed 59.89% in 2025 before it fell 19.26% in 2026.
- Over 3 years, Current Assets stood at $151.0 million in 2024, then surged by 59.89% to $241.4 million in 2025, then dropped by 8.47% to $221.0 million in 2026.
- Business Quant data shows Current Assets for SION at $221.0 million in Q1 2026, $241.4 million in Q4 2025, and $252.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 18.21 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 220.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220.96 Mn |
| Dec 31, 2025 | 241.42 Mn |
| Sep 30, 2025 | 252.33 Mn |
| Jun 30, 2025 | 266.75 Mn |
| Mar 31, 2025 | 273.68 Mn |
| Dec 31, 2024 | 150.99 Mn |